Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer

Joe J. Stephenson; John Nemunaitis; Anil A. Joy; Julie C. Martin; Ying-Ming Jou; Da Zhang; Paul Statkevich; Siu-Long Yao; Yali Zhu; Honghong Zhou; Karen Small; Rajat Bannerji; Martin J. Edelman

doi:10.1016/j.lungcan.2013.11.020

Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2013.11.020 ◽

2014 ◽

Vol 83 (2) ◽

pp. 219-223 ◽

Cited By ~ 47

Author(s):

Joe J. Stephenson ◽

John Nemunaitis ◽

Anil A. Joy ◽

Julie C. Martin ◽

Ying-Ming Jou ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Phase 2 ◽

Cyclin Dependent Kinase ◽

Small Cell Lung ◽

Cyclin Dependent Kinase Inhibitor ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

Abstract 2242: A randomized phase 2 study of the cyclin-dependent kinase (CDK) inhibitor Dinaciclib (SCH 727965) in patients with non-small cell lung cancer (NSCLC)

10.1158/1538-7445.am2011-2242 ◽

2011 ◽

Cited By ~ 2

Author(s):

Stephen L. Warren ◽

John Nemunaitis ◽

Joe Stephenson ◽

Benoit Samson ◽

Anil A. Joy ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Cdk Inhibitor ◽

Phase 2 ◽

Cyclin Dependent Kinase ◽

Small Cell Lung ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.2260 ◽

2015 ◽

Vol 93 (4) ◽

pp. 757-764 ◽

Cited By ~ 155

Author(s):

Gregory M.M. Videtic ◽

Chen Hu ◽

Anurag K. Singh ◽

Joe Y. Chang ◽

William Parker ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Stereotactic Body Radiation Therapy ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

Final Results of a Randomized Phase 2 Study Comparing Carboplatin Plus Irinotecan (Ci) Versus Carboplatin Plus Amrubicin (Ca) for Extensive Disease Small-Cell Lung Cancer: Njlcg0901

Annals of Oncology ◽

10.1093/annonc/mdu355.14 ◽

2014 ◽

Vol 25 ◽

pp. iv515

Author(s):

Y. Tsukita ◽

N. Morikawa ◽

S. Sugawara ◽

M. Maemondo ◽

T. Harada ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Extensive Disease ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2018.04.022 ◽

2018 ◽

Vol 123 ◽

pp. 14-21 ◽

Cited By ~ 10

Author(s):

Byoung Chul Cho ◽

Grace K. Dy ◽

Ramaswamy Govindan ◽

Dong-Wan Kim ◽

Nathan A. Pennell ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Cyclin Dependent Kinase ◽

Small Cell Lung ◽

Extensive Disease ◽

Phase Ib ◽

Cyclin Dependent Kinase Inhibitor

Download Full-text

Abstract 4606: Randomized phase 2 study of efatutazone in combination with carboplatin and paclitaxel as first-line therapy for metastatic non-small cell lung cancer (NSCLC)

10.1158/1538-7445.am2012-4606 ◽

2012 ◽

Author(s):

Alice T. Shaw ◽

Doru Ghizdavescu ◽

Minish Jain ◽

Constantin Volovat ◽

Deepa Subramaniam ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

Randomized phase 2 study of subcutaneous amifostine versus epoetin-α given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer

Cancer ◽

10.1002/cncr.23790 ◽

2008 ◽

Vol 113 (7) ◽

pp. 1623-1631 ◽

Cited By ~ 6

Author(s):

Hye-Suk Han ◽

Ji-Youn Han ◽

Sun Young Yu ◽

Hong Ryull Pyo ◽

Hyae Young Kim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Limited Disease ◽

Hyperfractionated Radiotherapy ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

A randomized phase 2 study of a human antiplatelet-derived growth factor α (PDGFRα) monoclonal antibody (olaratumab, IMC-3G3) with paclitaxel/carboplatin or paclitaxel/carboplatin alone in previously untreated patients with advanced non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8050 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8050-8050 ◽

Cited By ~ 1

Author(s):

David E. Gerber ◽

Toby Christopher Campbell ◽

Paul Swanson ◽

Ariel Lopez-Chavez ◽

Lucas Wong ◽

...

Keyword(s):

Lung Cancer ◽

Monoclonal Antibody ◽

Growth Factor ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study ◽

Factor Α ◽

Randomized Phase 2

Download Full-text

A randomized phase 2 study of abemaciclib versus docetaxel in patients with stage IV squamous non-small cell lung cancer (sqNSCLC) previously treated with platinum-based chemotherapy.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.9059 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 9059-9059

Author(s):

Giorgio V. Scagliotti ◽

Igor Bondarenko ◽

Tudor-Eliade Ciuleanu ◽

Maciej Bryl ◽

Andrea Fülöp ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Platinum Based Chemotherapy ◽

Phase 2 Study ◽

Previously Treated ◽

Randomized Phase 2

Download Full-text

Randomized phase 2 study of carboplatin plus irinotecan (CI) versus carboplatin plus amrubicin (CA) for extensive disease small-cell lung cancer (ED-SCLC): NJLCG0901.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.7521 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 7521-7521

Author(s):

Yosuke Kawashima ◽

Naoto Morikawa ◽

Shunichi Sugawara ◽

Makoto Maemondo ◽

Toshiyuki Harada ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Extensive Disease ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC)

Cancer ◽

10.1002/cncr.31779 ◽

2018 ◽

Vol 124 (24) ◽

pp. 4667-4675 ◽

Cited By ~ 3

Author(s):

Daniel Morgensztern ◽

Manuel Cobo ◽

Santiago Ponce Aix ◽

Pieter E. Postmus ◽

Conrad R. Lewanski ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text